Research Notes: Can Cannabis Stocks Make A Comeback? (Part 1)
Cannabis producers have been awful investments. There's reason to believe it can get better
The “green rush” in cannabis stocks has turned to a crushing disappointment, with the largest plays down more than 90%.
Canopy Growth has collapsed below $1 — and yet it does seem like, somehow, the company should be able to salvage some value.
Tilray looks like a winner if the Canadian industry finally becomes rational, but that day may never arrive.
Cronos is seeing takeover interest, but a deal seems unlikely. Should CRON plunge, deep value investors should take a good look.